Ambit Micro Marvels Portfolio PMS Review: Performance, Fees & Should You Stay Invested?

Quick Summary

What Works	What Doesn’t
Genuine micro-cap and small-cap mandate — average market cap of just ₹2,446.83 crore, staying true to what it promises rather than drifting toward safer, larger names	No 2-year, 3-year, or 5-year trailing track record exists yet — the strategy is only 1 year and 11 months old
Sharp recent rebound — 33.70% return over the last 3 months and 6.07% over 6 months, both well ahead of the benchmark	1-year return of -3.36% and a since-inception return of -6.58%, both behind the S&P BSE 500 TRI
Fund manager with two decades of dedicated small and micro-cap research experience, including a recognised industry track record	A 15% profit-sharing fee with a 0% hurdle — meaning the fee applies from the very first rupee of profit, not after a minimum return threshold
No style drift — 99% of the portfolio sits in small and micro-cap names, exactly as the mandate describes	Very high concentration, with the top 5 sectors making up 84% of the portfolio

The verdict: You are looking at a young, volatile, high-conviction micro-cap strategy that has swung from a rough first year to a sharp recent recovery — and simply hasn’t been running long enough to prove whether it earns its fee over a full market cycle.

That is not the same conclusion as our review of a longer-running PMS, and it deserves a more patient, evidence-first read — which is exactly what follows.

Table of Contents:

1. Who Should Read This
2. Who This PMS May Still Suit
3. Who Should Likely Avoid This PMS
4. What Is the Ambit Micro Marvels Portfolio?
5. The PMS Value Framework
6. Performance Review
7. The Fee Reality
8. The Zero-Based Thinking Test
9. Decision Factor Scorecard
10. Summary Scorecard
11. The Core Portfolio Architecture Question
12. What a Genuinely Complementary PMS Looks Like
13. Exit Considerations
14. Key Takeaways
15. FAQs
16. Our Approach

Who Should Read This

• You are currently invested in the Ambit Micro Marvels Portfolio and want an honest read on its short but eventful track record
• You are evaluating a micro-cap PMS mandate and want to understand what a 15% no-hurdle profit share actually costs you
• You already hold small-cap or micro-cap-oriented mutual funds and want to know whether this PMS is genuinely differentiated or simply another basket of small names
• You are within your first exit-load window and are deciding whether to continue, hold, or step back before the strategy has a longer track record
• You want a fair, data-first read — not a verdict dressed up as certainty on a fund that is barely two years’ old

Who This PMS May Still Suit

• An investor who deliberately wants dedicated micro-cap exposure — the smallest, least-covered end of the listed universe — and understands this is inherently higher-risk than mainstream small-cap investing
• Someone with a genuinely long horizon, 7 to 10 years or more, who is comfortable giving a young strategy the time it needs to demonstrate a full cycle
• An investor drawn to Bhargav Buddhadev’s specific research pedigree in under-covered small and micro-cap names, and who values manager continuity — he has run this exact mandate since its inception
• Someone who can independently verify that the current 32 holdings-level concentration in the top 5 stocks does not meaningfully duplicate their existing mutual fund exposure

Who Should Likely Avoid This PMS

• If you need a proven, full-cycle track record before committing capital, this strategy simply does not have one yet — the data does not exist to judge it on a 3-year or 5-year basis
• If you are uncomfortable with sharp short-term swings — a portfolio that has moved from a rough first year to a 33.70% three-month rally is, by definition, a volatile one
• If you already hold small-cap mutual funds and have not compared actual holdings, you may be adding concentration risk rather than diversification
• If a 15% profit share with no hurdle rate feels aggressive to you for an unproven strategy, that discomfort is worth listening to

What Is the Ambit Micro Marvels Portfolio?

Here is the strategy in plain terms: Ambit Investment Advisors Pvt Ltd runs the Micro Marvels Portfolio as a PMS mandate that aims to build a portfolio predominantly invested in small- and micro-cap companies, selected for clean governance, prudent capital allocation, and the potential for sustained long-term earnings growth.

That is the promise. Below is what the data — as on 30 June 2026 — actually shows.

Key Fact	Detail
AMC	Ambit Investment Advisors Pvt Ltd (Ambit Asset Management)
Strategy	Ambit Micro Marvels Portfolio
Category	PMS — Micro Cap
Fund Manager	Bhargav Buddhadev
Benchmark	S&P BSE 500 TRI
Inception Date	29 July 2024
Portfolio Age	1 year, 11 months
Minimum Investment	₹50,00,000
AUM	₹395.42 crore
Market Cap Mix	Small & Micro Cap 99% · Cash & Equivalent 1%
Average Market Cap	₹2,446.83 crore
Top 5 Stock Concentration	32.00%
Top 5 Sector Concentration	84.00%

Bhargav Buddhadev brings over 20 years of experience in investment management and equity research, with a strong specialisation in mid- and small-cap companies.

He previously contributed to investment decision-making for mid- and small-cap funds at Kotak Mutual Fund, and earlier led mid-cap research at Ambit Institutional Equities, where he created the Beachcombing Series — a small-cap research product built on extensive on-ground channel checks with competitors, suppliers, and distributors.

He was ranked among the top analysts in the 2017 Asiamoney Polls for Consumer Discretionary, Small Caps, Utilities, and Conglomerates, and holds both a Chartered Accountancy qualification and an MBA in Finance.

He has managed this specific strategy since its inception, which means there is no manager-continuity question to raise here — the person who designed the mandate is the person who has executed it from day one.

Two honest notes before we move on.

First, SEBI does not define “micro-cap” as a separate regulatory market-cap category — only large, mid, and small cap exist formally — so on a standardised composition chart, this portfolio’s 99% micro and small-cap allocation shows up simply as “Small Cap.”

Second, the exact total stock count and two of the portfolio’s top five sector names were not fully rendered in the public data we reviewed for this analysis.

That is not unusual, and we are not treating it as a transparency concern — this level of granular detail is the kind of thing Ambit’s team will walk you through directly if you are a prospect or existing investor, and you should ask for it.

The mandate does execute what it says on paper — this is a genuine, undiluted micro and small-cap portfolio, with an average market cap of under ₹2,500 crores.

Where the story needs more nuance is in the return pattern.

The PMS Value Framework

Before diving into the detailed data, here is the lens we use to evaluate every PMS we review:

Gross Alpha > Fee = Value Added | Gross Alpha ≈ Fee = Break-Even | Gross Alpha < Fee = Value Destroyed

For a PMS to genuinely earn its premium fee, the value it generates over the benchmark — before fees — needs to comfortably exceed what it charges you.

Where does the Ambit Micro Marvels Portfolio sit on this framework today?

Based on the only annualised, net-of-fee figure available — the since-inception return of -6.58%, against a benchmark return of 0.16% — this strategy currently sits closer to the value-destroyed zone.

But we want to be direct about the limits of that statement: this is a 23-month-old strategy, and the last three and six months alone have added 33.70% and 6.07% respectively.

A short, volatile history should not be mistaken for a verified verdict. It is an early signal, not a final one.

Performance Review

Let’s start with the question you should be asking yourself: when did you last actually check whether this PMS is beating its benchmark, net of fees — and did you notice how differently the last three months read compared to the last twelve?

Here is the full trailing return picture, as on 30 June 2026, compared with the portfolio’s own stated benchmark:

Period	Ambit Micro Marvels Portfolio	S&P BSE 500 TRI (Benchmark)	Alpha (+/-)
1 Month	8.14%	1.73%	+6.41%
3 Month	33.70%	12.10%	+21.60%
6 Month	6.07%	-3.53%	+9.60%
1 Year	-3.36%	1.96%	-5.32%
Since Inception	-6.58%	0.16%	-6.74%

The 2-year, 3-year, and 5-year rows are not shown here — the strategy is only 1 year and 11 months old, so this data simply does not exist yet.

Here is the thing — this table tells two different stories depending on which window you look through.

Over the last one, three, and six months, this portfolio has meaningfully beaten its benchmark, and by a wide margin.

Over the last year and since inception, it has trailed. Both of those things are true at the same time.

What likely happened here is fairly straightforward.

Micro and small-cap stocks went through a genuine correction phase for a stretch of this portfolio’s short life, dragging both the 1-year and since-inception numbers into negative territory.

The sharp rebound in the last two quarters suggests that phase may be turning — but two strong quarters is not the same as a demonstrated cycle.

Small and micro-cap portfolios are, by their nature, more volatile than a broad, diversified benchmark, and short performance windows in either direction should be read with real caution.

So is this underperformance temporary or structural?

Honestly — we do not have enough data to say with confidence, and neither does anyone reviewing this fund.

A strategy needs to move through at least one full up-and-down cycle before that question can be answered responsibly.

What we can tell you is this: the recent recovery is real and worth acknowledging, but it does not erase the fact that an investor who has held this PMS since inception is still behind the benchmark today, net of fees, on a cumulative basis.

For additional context, actively managed small-cap mutual funds — the closest available comparison category, since India does not have a formally classified micro-cap mutual fund category — have delivered an average 1-year return of roughly 11.13%.

Against that yardstick, this PMS’s -3.36% 1-year return trails not just its own benchmark, but the average outcome from a plain small-cap mutual fund, by close to 14.5 percentage points.

That gap deserves your attention regardless of how the next quarter turns out.

The Fee Reality

Here is the thing. A fee is not inherently a problem.

A fee is only a problem when it is not earning its keep — and it is worth understanding exactly what you are agreeing to pay here, because the structure is more aggressive than what you may be used to.

Fee structure, stated clearly:

• Fixed Fee: 2.50% per annum (AMC)
• Variable Fee: 15% profit share on profits, with a 0% hurdle — meaning there is no minimum return threshold the fund must clear before the profit share applies
• Exit Load: 3.00% in Year 1, 2.00% in Year 2 (no rate beyond Year 2 was specified in the data we reviewed — confirm the full schedule directly with Ambit)

Notice the difference from a hurdle-based fee structure: with a 0% hurdle, the moment this portfolio turns a profit in a given period, 15% of that profit is shared with the fund manager — there is no “you get the first 8% and we share what’s above that” cushion built in.

That is a meaningfully different arrangement from PMS strategies that only take a performance fee above a stated hurdle rate, and it is worth understanding fully before your next review cycle.

Fee Drag on ₹50 Lakhs: The Rupee Picture

Scenario	Gross Return Assumed (Estimated)	Corpus After 5 Years	Corpus After 7 Years
Ambit Micro Marvels Portfolio (Net, at since-inception CAGR of -6.58%)	-6.58%	₹35.58 lakh	₹31.05 lakh
Active MF Category Average — Small Cap (Net, at category 5-year CAGR of 16.90%)	16.90%	₹1.09 crore	₹1.49 crore

We want to be transparent about what this table is and is not.

It is not a prediction — it takes the only annualised rate this strategy has actually produced over a period longer than a year (its own since-inception number) and projects it forward, which is a standard way to illustrate fee drag, but it is built on just 23 months of unusually volatile data that includes both a weak start and a strong recent rebound.

Read the gap as a caution flag, not a forecast: if the current trend continues unchanged, the compounding cost of staying in a strategy that trails a plain small-cap mutual fund category average — while paying 2.5% fixed plus a no-hurdle 15% profit share — is real money.

If the recent three-month strength continues instead, this picture would look very different.

That uncertainty is precisely why a longer track record matters before drawing firm conclusions.

The Zero-Based Thinking Test

Here is a question worth sitting with for a moment: knowing everything you know today — the volatile first year, the recent rebound, the fee structure, the lack of a 3-year or 5-year track record — if you were starting fresh with this same ₹50 lakhs right now, would you invest it in this same product?

Not “should I stay because I’ve already committed.” Just: knowing what you now know, would you choose this again?

This is not a trick question, and it is not designed to make you feel foolish. You invested in a young strategy with a credible manager and a clear mandate.

That is a reasonable decision to have made in 2024.

The information available to you has since expanded — you now have 23 months of actual performance data where you previously had none.

Here is what tends to happen instead.

Investors stay invested because of a “wait and see” instinct that never actually resolves — because the recent good quarter feels like validation, or because reviewing a PMS statement feels like more effort than doing nothing.

Neither of those is a real answer to the question above.

Flip the framing. Staying invested should require the same scrutiny as a fresh decision — not less, and not more just because the recent numbers looked good.

If you would sign this same contract today, knowing what you now know, that is a legitimate, informed choice to keep holding.

If you would not, staying is not the neutral option — it is an active decision that deserves its own justification.

Decision Factor Scorecard

Decision Factor	Rating	Analysis
Uniqueness vs. existing MF portfolio	🟢 Pass	The portfolio’s top holdings — Thejo Engineering, Sanstar, Globus Spirits, Platinum Industries, and Entero Healthcare Solutions — sit well below the size and visibility of names typically held in mainstream diversified mutual funds. With an average market cap of ₹2,446.83 crore, this genuinely reaches into a part of the market that most flexi-cap, multi-cap, and even many small-cap mutual funds structurally cannot access at scale.
Alpha consistency across all periods	🟡 Mixed	This is a genuinely two-sided picture. The 1-month, 3-month, and 6-month alpha figures are strongly positive — +6.41%, +21.60%, and +9.60% respectively. The 1-year and since-inception alpha are both negative, at -5.32% and -6.74%. No 2-year, 3-year, or 5-year data exists yet to tell us which pattern will dominate over a full cycle.
Justification for PMS premium fee	🟡 Mixed	Net-of-fee returns since inception trail both the benchmark and the small-cap active mutual fund category average on a 1-year basis. That is a real concern. But with only 23 months of history — and a fee structure (0% hurdle, 15% profit share) that has not yet been tested through a full market cycle — it would be premature to issue a final verdict on value either way.
Downside protection in market corrections	🟡 Mixed	The portfolio’s -3.36% 1-year return against a benchmark of +1.96% suggests limited downside cushioning during whatever correction phase this strategy experienced in its first year. But the strategy has not yet lived through a full, well-defined market cycle, so this cannot be judged conclusively either way.
Portfolio complement for MF investor	🟢 Pass	With 99% of the portfolio genuinely in small and micro-cap names at an average market cap well under ₹2,500 crore, this strategy reaches a segment of the market that is structurally very different from what most mutual fund portfolios hold, even dedicated small-cap funds whose average holdings tend to be larger.
Mandate purity and discipline	🟢 Pass	Despite a rough first year, the portfolio has not drifted toward larger, “safer” names to protect near-term optics. The 99% small-and-micro-cap allocation and sub-₹2,500 crore average market cap confirm the mandate is being executed as stated, not diluted under pressure.
Fund manager transparency	🟢 Pass	Bhargav Buddhadev has a well-documented, verifiable career — Kotak Mutual Fund, Ambit Institutional Equities, and a recognised Asiamoney Polls ranking. Some granular data, including the exact stock count and two sector labels, were not fully visible on the public source we reviewed, but this is standard for public factsheet portals; that detail is available directly from Ambit to prospects and existing investors, and it should not be read as a transparency gap on the manager’s part.
Investment horizon suitability	🟡 Mixed	At 1 year and 11 months old, this strategy has simply not been given the time a micro-cap mandate typically needs — 5 to 7 years at minimum — to prove itself. If your horizon is shorter than that, the strategy has not had, and will not get, a fair runway within your timeframe.
Market cap flexibility utilisation	🟢 Pass	This is not a flexible-mandate strategy, and it does not pretend to be one. It has stayed a focused, undiluted small-and-micro-cap portfolio throughout its short life, which is exactly what a micro-cap-labelled PMS should do.
Concentration vs. diversification balance	🔴 Concern	Top 5 sectors account for 84.00% of the portfolio — an unusually high concentration, even for a conviction-driven micro-cap strategy. Combined with the inherently lower liquidity of micro-cap stocks, this level of sector concentration adds a meaningful layer of risk that has not yet been offset by a demonstrated, multi-year alpha track record.
AUM size and strategy capacity	🟡 Mixed	At ₹395.42 crore, the AUM is sizeable for a strategy investing in stocks with an average market cap of roughly ₹2,446 crore. True micro-cap investing has tighter capacity limits than mid or small-cap strategies, because entering and exiting less liquid stocks at scale is harder. This is not disqualifying today, but it is worth watching as the strategy potentially gathers more assets.
Manager tenure and continuity risk	🟢 Pass	Bhargav Buddhadev has managed this exact strategy since its inception in July 2024, with no manager change. Combined with over two decades of dedicated small and micro-cap research experience, continuity risk here is low — the person accountable for the mandate’s design is the person who has executed it throughout.
Track record maturity	🔴 Concern	This is the single most important caveat in this entire review: there is no 2-year, 3-year, or 5-year return data for this strategy, because it does not yet exist. Any conclusion about whether this PMS earns its fee over a genuine market cycle is, by definition, not yet possible to draw with real confidence.

Summary Scorecard

Decision Factor	Rating
Uniqueness vs. existing MF portfolio	🟢
Alpha consistency across all periods	🟡
Justification for PMS premium fee	🟡
Downside protection in market corrections	🟡
Portfolio complement for MF investor	🟢
Mandate purity and discipline	🟢
Fund manager transparency	🟢
Investment horizon suitability	🟡
Market cap flexibility utilisation	🟢
Concentration vs. diversification balance	🔴
AUM size and strategy capacity	🟡
Manager tenure and continuity risk	🟢
Track record maturity	🔴

The Core Portfolio Architecture Question

Here is a way of thinking about your total portfolio that has nothing to do with any single product: a core portfolio, built on low-cost, diversified mutual funds — index funds, flexi-cap, multi-asset — that you can hold through every market cycle without worrying about manager-specific or track-record risk.

And a satellite portfolio, made up of selective PMS and AIF strategies, whose entire job is to genuinely complement the core, not duplicate it, by reaching opportunities your mutual funds structurally cannot.

The test for any satellite holding is simple: does it access something your core cannot?

And — for a strategy this young — has it earned the right to a larger allocation, or does it deserve to stay small and closely watched until it has a longer track record behind it?

That is the lens worth applying here, and to any PMS you hold.

What a Genuinely Complementary PMS Looks Like

Without naming any specific product, here is what separates a satellite holding that earns its place from one that does not:

• It generates consistent net-of-fee alpha across multiple market cycles, not just a favourable one-quarter or two-quarter window
• It holds stocks or market-cap segments that your existing mutual fund portfolio genuinely cannot access efficiently
• It demonstrates a track record long enough — ideally spanning at least one full up-and-down cycle — to be judged with real confidence
• Its fee structure, including any hurdle rate, is proportionate to the risk and volatility of the segment it invests in
• Its mandate discipline is verifiable — the manager sticks to the stated strategy through pressure, rather than drifting under short-term performance stress

Exit Considerations

If you do decide to exit, here is exactly what it costs you and how it works:

• Exit load: 3.00% if you exit in Year 1, 2.00% in Year 2. The schedule beyond Year 2 was not specified in the data we reviewed, so confirm this directly with Ambit before acting
• Tax treatment: PMS holdings are taxed at the stock level, not at the portfolio level. Each individual stock sale within the portfolio is subject to capital gains tax based on its own holding period — short-term or long-term — rather than being treated as a single mutual-fund-style redemption
• Staggered exit: Given the stock-level tax treatment, a phased exit — spread over a few tranches — can help manage the capital gains impact more efficiently than an all-at-once redemption, and is worth discussing given the strategy’s recent volatility
• Timing: Given this strategy is mid-recovery after a rough first year, timing an exit purely on recent momentum is risky in either direction. The decision should rest on your horizon and conviction in the mandate, not on chasing or fleeing a single strong quarter

Key Takeaways

1. The Ambit Micro Marvels Portfolio is only 1 year and 11 months old — there is no 2-year, 3-year, or 5-year trailing return data available yet
2. The last 1, 3, and 6-month returns show strong positive alpha against the benchmark; the 1-year and since-inception returns show negative alpha — both are real and worth holding in mind together
3. The 1-year return of -3.36% trails not just the benchmark, but the average return from a plain active small-cap mutual fund by roughly 14.5 percentage points
4. The fee structure includes a 15% profit share with a 0% hurdle, meaning performance fees apply from the first rupee of profit — more aggressive than a hurdle-based structure
5. The portfolio has stayed genuinely true to its micro and small-cap mandate, with a ₹2,446.83 crore average market cap and no drift toward larger, safer names
6. Sector concentration is high, with the top 5 sectors making up 84% of the portfolio
7. Because the strategy has not yet completed a full market cycle, any judgment on whether it structurally underperforms or is simply working through a volatile early phase remains genuinely open
8. Whether this PMS deserves a place in your portfolio today depends on your comfort with that uncertainty — and your time horizon to let it resolve

FAQs

Q1. Is the Ambit Micro Marvels Portfolio a good or bad PMS?

Based on the data available of Ambit Micro Marvels Portfolio PMS, it is too early to issue a definitive verdict. The 1-year and since-inception returns trail the benchmark, but the strategy is under 2 years old and has no multi-year track record to confirm whether this is a temporary phase or a structural issue.

Q2. What is the minimum investment for the Ambit Micro Marvels Portfolio PMS?

The minimum investment for the Ambit Micro Marvels Portfolio PMS is ₹50,00,000, in line with SEBI’s regulatory floor for portfolio management services.

Q3. What does a 0% hurdle mean in a PMS fee structure?

It means the fund manager’s profit share applies from the very first rupee of gains, with no minimum return threshold the strategy must clear first. This is more aggressive than a hurdle-based structure, where the manager only shares in profits above a stated benchmark rate.

Q4. How does PMS underperformance compare to mutual fund underperformance?

A mutual fund’s expense ratio is typically far lower than a PMS’s fixed-plus-variable structure, so underperformance in a PMS compounds a larger fee drag on top of weaker returns — a double disadvantage.

Q5. How is PMS taxed compared to mutual funds?

PMS holdings are taxed at the individual stock level — each stock’s sale triggers its own short-term or long-term capital gains calculation, unlike a mutual fund where you are taxed only on your own unit redemption.

Q6. How do I exit a PMS?

You instruct the fund manager to liquidate holdings, fully or in stages. Given the stock-level tax treatment, a staggered exit is often more tax-efficient than a single lump-sum instruction.

Q7. Is a micro-cap PMS riskier than a small-cap mutual fund?

Generally, yes. Micro-cap companies are smaller, less liquid, and less analysed than mainstream small-cap stocks, which typically means higher volatility in both directions — as this portfolio’s own swing from a rough first year to a strong recent rebound illustrates.

Q8. Should I judge a PMS on its since-inception return alone?

Not in isolation, especially for a young strategy. Since-inception figures for a fund under 2 years old can be heavily skewed by a single strong or weak stretch. A longer track record, ideally spanning a full market cycle, gives a far more reliable picture.

Q9. What is a core and satellite investment strategy?

It is a portfolio construction approach where your core holdings — typically low-cost, diversified mutual funds — provide broad, dependable market exposure, while a smaller satellite allocation to PMS or AIF strategies is used selectively to access opportunities the core structurally cannot reach.

Q10. Does AUM size matter for a micro-cap PMS?

Yes, more than for most other categories. Micro-cap stocks have limited liquidity, so a strategy’s AUM needs to stay proportionate to what it can efficiently buy and sell without moving prices. At ₹395.42 crore against a ₹2,446.83 crore average market cap, this is worth monitoring as the strategy grows.

Our Approach

We do work with select PMS strategies as part of a satellite allocation for clients — but this is not one we currently recommend, given how limited its track record still is.

If you already hold this PMS alongside mutual funds, we’re happy to sit down with you as your CFP and map both portfolios side by side, so you can see clearly whether this holding is genuinely complementing your mutual fund allocation or simply overlapping with it.